Trial Profile
Phase Ib, Single-Centre, Placebo-Controlled Randomised Study of Safety, Tolerability and Pharmacokinetics of Elpida in Healthy HIV-Uninfected Volunteers
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 May 2021
Price :
$35
*
At a glance
- Drugs Elsulfavirine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Viriom
- 16 May 2019 Planned End Date changed from 1 Jan 2019 to 1 Dec 2019.
- 16 May 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Nov 2019.
- 16 May 2019 Planned initiation date changed from 1 Dec 2018 to 1 May 2019.